Renda Kangjian

China
Xiaqiaotou, Yunnan, China

Company profile

Renda Kangjian company profile

Renda Kangjian is an anti-Alzheimer's medicine developer company fosused on the research and development of the anti-Alzheimer's drug - Huperzine A.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2021-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$413,582
Last funding
Seed / $413,582 / 2024-06-18
Last equity funding
Seed / $413,582

Founders and investors

No public relation records are available.